APAC Epilepsy Therapeutics Market Analysis

$3,000.00$7,500.00

  • Type: Therapeutics Area
  • Published : January 2022
  • Region: APAC
  • Country: Other
  • Report ID : 5042

  • Format: PPT, PDF

APAC Epilepsy Therapeutics Market Analysis: Segmented by Product, Geography- Growth, Market Size, Future Prospects & Competitive Analysis, 2020 – 2028

Clear
SKU: 5042 Categories: ,

Report Description of the APAC Epilepsy Therapeutics Market Analysis

Research Scope and Assumption

  • The report provides the market value for the base year 2020 and a yearly forecast up to 2028 in terms of revenue (USD billion)
  • The key industry dynamics, regulatory scenario, reimbursement scenario, major market trends, and drug markets are evaluated to understand their impacts on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis
  • We have used the combination of top-down and bottom-up approach for market sizing, analyzing key regional markets, dynamics, and trends for various solutions, services, and end uses
  • All market estimates and forecasts have been validated through primary interviews with the Key Industry Players (KIPs) and secondary analysis
  • Inflation has not been accounted for in order to estimate and forecast the market
  • Numbers may not add up due to rounding off

Reason to buy the report:

  • Facilitate decision-making based on strong current and forecast data for APAC Epilepsy Therapeutics  Market  Analysis
  • Develop strategies based on the latest regulatory framework
  • Strategically analyze micro-markets with respect to individual growth trends, future prospects, and their contribution to the market
  • Analyze competitive developments such as expansions, investments, mergers & acquisitions, new product developments, and research & developments in the APAC Epilepsy Therapeutics  Market  Analysis
  • Analyze the opportunities in the market for stakeholders and draw a competitive landscape for market leaders
  • To strategically profile key players and comprehensively analyze their market shares and core competencies
  • We have technically sound team which do a deep dive research and also provide strategy based consulting analysis

APAC Epilepsy Therapeutics Market Analysis Executive Summary

Epilepsy is a common condition that affects the brain and causes frequent seizures. Seizures are bursts of electrical activity in the brain that temporarily affect how it works. They can cause a wide range of symptoms. Epilepsy can start at any age, but usually starts either in childhood or in people over 60. It’s often lifelong, but can sometimes get slowly better over time.

Market Size and Key Findings

The APAC Epilepsy Therapeutics Market Analysis size stood at around USD xx billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of 4.01% during the forecast period.

The epilepsy therapeutics market in APAC has the potential to grow by USD 296.44 million during 2020-2028, and the market’s growth momentum will accelerate at a CAGR of 4.01%.

Market Dynamics

Market Growth Drivers Analysis

The market is driven by the high unmet medical need, increase in patient population, and rising awareness. In addition, high unmet medical need is anticipated to boost the growth of the market as well. The market is driven by the increase in the patient population.

Market Restraints

The technological advancements in non-invasive neuromodulation and seizure management devices may impede market growth.

COVID-19 impact on “APAC Epilepsy Therapeutics Market”

The COVID-19 pandemic continues to transform the growth of various industries; however, the immediate impact of the outbreak is varied. While a few industries will register a drop in demand, numerous others will continue to remain unscathed and show promising growth opportunities. COVID-19 will have at Par impact on the Epilepsy Therapeutic market in APAC.

Competitive Landscape

Key Players

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading epilepsy therapeutic market in APAC vendors that include Bausch Health Companies Inc., BIAL – PORTELA & CA SA, GlaxoSmithKline Plc, Johnson & Johnson Services, Inc., Novartis AG, Pfizer Inc., SanofiSA, Sunovion Pharmaceuticals Inc., UCB SA, and Zogenix Inc. Also, the epilepsy therapeutic market in APAC analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

Products in Pipeline

Second generation AEDs with newer mechanisms of action, such as Keppra (levetiracetam), Zonegran (zonisamide) and Vimpat (lacosamide), have signaled a shift in the last decade with improved tolerability and efficacy. Recent approvals, including Fycompa (perampanel) and Trobalt (retigabine) have continued this trend by focusing on new molecular targets.

Notable Recent Deals

  • The Epilepsy Foundation’s Shark Tank Competition seeks to advance innovative ideas in epilepsy seizure treatment and care. The winners will use their prize to accelerate their innovation to the next phase of development and closer to being accessible to people living with epilepsy. In total, 35 individuals or teams entered the competition from across the United States and 8 countries throughout the world. From this pool, 5 teams were chosen as finalists. The finalists presented on May 24, 2019, at the 2019 Antiepileptic Drug & Device (AEDD) Trials XV Conference in Florida.

Healthcare Policies and Regulatory Landscape

Policy changes and Reimbursement scenario

At the 65th WHO Western Pacific Regional Committee meeting (65th WPRCM),which was held in Manila, Philippines, October 13–17, 2014, a representative of the IBE (Chairman of the ILAE/IBE Research Advocacy Task Force) made a statement to call for a “WHO Western Pacific Strategic Action for Epilepsy”: through coordinated efforts at country level designed to:

  • assess the size of the epilepsy burden and related specificities and needs;
  • (ii) introduce and implement national epilepsy programs and services in accordance with international human rights norms and standards;
  • (iii) minimize the gaps in diagnosis and treatment, by addressing inequalities in care and facilitating access to affordable medicines and other treatments;
  • (iv) enact legislation to protect the rights of people with epilepsy; and
  • (v) establish awareness initiatives to educate the public about the nature of the disease and thereby remove stigmatization. The response and effects of the call, however, were not satisfactory.

 

[wpforms id=”38613″]

1. Report Description of the APAC Epilepsy Therapeutics Market Analysis
1.1 Research Scope and Assumption
1.2 Objective of the study
1.3 Research Methodology
1.4 Reason to buy the report
2. APAC Epilepsy Therapeutics Market Analysis Executive Summary
2.1 APAC Epilepsy Therapeutics Market Analysis – Industry Snapshot & key buying criteria, 2020-2028
2.2 Market Size, Growth Prospects and Key findings
3. Market Dynamics of APAC Epilepsy Therapeutics Market Analysis
3.1 Market Growth Drivers Analysis
3.1.1 High unmet medical need
3.1.2 Increase in patient population
3.2 Market Restraints Analysis
3.2.1 The technological advancements
3.3 Covid-19 Market Impact Analysis
4. APAC Epilepsy Therapeutics Market Segmentation
4.1 By Product:
4.1.1 First-generation epilepsy therapeutics
4.1.2 Second-generation epilepsy therapeutics
4.1.3 Third-generation epilepsy therapeutics
4.2 By Geography:
4.2.1 Asia
4.2.2 Rest of APAC
5. APAC Epilepsy Therapeutics Market Share
5.1 Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape
6.1 Major Top Market Players
6.2 Products in Pipeline
6.3 R&D Initiatives in Epilepsy Therapeutics Market
6.4 Notable recent deals in Epilepsy Therapeutics Market
6.4.1 Joint Ventures
6.4.2 Partnerships
6.4.3 Mergers & Acquisitions
6.4.4 Strategic divestments
7. Key Company Profiles
7.1 Johnson & Johnson Services, Inc. Company overview
Product & Services, Strategies & Financials
7.2 GlaxoSmithKline Plc Company overview
Product & Services, Strategies & Financials
7.3 Pfizer Inc. Company overview
Product & Services, Strategies & Financials
7.4 Novartis AG Company overview
Product & Services, Strategies & Financials
7.5 Sanofi SA Company overview
Product & Services, Strategies & Financials
7.6 Sunovion Pharmaceuticals Inc. Company overview
Product & Services, Strategies & Financials
7.7 Zogenix Inc. Company overview
Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape
8.1 Policy changes and Reimbursement scenario
8.2 Government Initiatives / Intervention programs
9. Factors Driving Future Growth
9.1 New Trends and Development of Epilepsy Therapeutics market
9.2 Future Opportunities
10. Strategic Recommendations

APAC Epilepsy Therapeutics Market Analysis Segmentation

By Product:

The epilepsy therapeutics market share growth in APAC by the first-generation epilepsy therapeutics segment will be significant during the forecast period. The first-generation AEDs include benzodiazepines, carbamazepine, phenytoin, valproic acid, and phenobarbital. These drugs usually require close monitoring and often lead to life-threatening reactions.

By Geography:

76% of the market’s growth will originate from Asia during the forecast period. Japan, China, India, and South Korea (Republic of Korea) are the key markets for epilepsy therapeutics in Asia. However, market growth in Asia will be slower than the growth of the market in the rest of APAC.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.



    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements